Xact Kapitalforvaltning’s Agios Pharmaceuticals AGIO Stock Holding History

Xact Kapitalforvaltning’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$270K	Hold	7,623	–	–	0.01%	1067
2019 Q4	$364K	Hold	7,623	–	–	0.01%	1151
2019 Q3	$247K	Hold	7,623	–	–	﹤0.01%	1300
2019 Q2	$380K	Hold	7,623	–	–	0.01%	1086
2019 Q1	$514K	Sell	7,623 -5,700	-43%	-$332K	0.01%	902
2018 Q4	$614K	Buy	13,323 +5,500	+70%	+$339K	0.02%	745
2018 Q3	$603K	Hold	7,823	–	–	0.01%	836
2018 Q2	$659K	Buy	7,823 +900	+13%	+$78.5K	0.01%	759
2018 Q1	$566K	Buy	6,923 +2,400	+53%	+$186K	0.01%	764
2017 Q4	$259K	Buy	+4,523	New	+$285K	0.01%	1051

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Xact Kapitalforvaltning's AGIO Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Agios Pharmaceuticals (AGIO) position steady in Q1 2020 at 7,623 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #1067.

Xact Kapitalforvaltning first reported a position in AGIO in Q4 2017 and has held it in 10 quarters since. The position peaked at $659K in Q2 2018. 198 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

Xact Kapitalforvaltning held 7,623 shares of Agios Pharmaceuticals worth $270K as of Q1 2020.
Xact Kapitalforvaltning left its Agios Pharmaceuticals share count unchanged in Q1 2020.
Agios Pharmaceuticals made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1067 holding.
Xact Kapitalforvaltning first reported a position in Agios Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Agios Pharmaceuticals position peaked at $659K in Q2 2018.
198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.